Resmed Inc Stock Today
| RMD Stock | USD 177.61 3.78 2.17% |
Performance1 of 100
| Odds Of DistressLess than 5
|
ResMed is trading at 177.61 as of the 19th of April 2024, a 2.17% increase since the beginning of the trading day. The stock's lowest day price was 176.33. ResMed has under 5 % chance of experiencing financial distress over the next 2 years but had a somewhat weak performance during the last 90 days. Equity ratings for ResMed Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 2nd of June 1995 | Category Healthcare | Classification Health Care |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. The company has 147.09 M outstanding shares of which 7.89 M shares are at this time shorted by investors with about 6.91 days to cover. More on ResMed Inc
ResMed Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ResMed's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ResMed or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, ResMed's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ResMed's managers, analysts, and investors.
Environment Score | Governance Score | Social Score |
| CEO | Michael Farrell | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Names | [RENO DE MEDICI, Reno De Medici S.p.A] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, SPASX 100, SPASX 300, Medical Equipment, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Excise Tax Activities | Animal Testing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering ResMed report their recommendations after researching ResMed's financial statements, talking to executives and customers, or listening in on ResMed's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering ResMed Inc. The ResMed consensus assessment is calculated by taking the average forecast from all of the analysts covering ResMed. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from ResMed's historical financial statements, ResMed Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of ResMed Inc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ResMed's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to ResMed's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand ResMed's financial leverage. It provides some insight into what part of ResMed's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ResMed Inc (RMD) is traded on New York Stock Exchange in USA. It is located in 9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123 and employs 40 people. ResMed is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 27.19 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ResMed's market, we take the total number of its shares issued and multiply it by ResMed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ResMed Inc runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 147.09 M outstanding shares of which 7.89 M shares are at this time shorted by investors with about 6.91 days to cover.
ResMed Inc has about 273.71 M in cash with 693.3 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87.
Check ResMed Probability Of Bankruptcy
Ownership AllocationResMed Inc has a total of 147.09 Million outstanding shares. Over half of ResMed's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in ResMed. Please watch out for any change in the institutional holdings of ResMed Inc as this could mean something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check ResMed Ownership Details
ResMed Stock Price Odds Analysis
What are ResMed's target price odds to finish over the current price? Based on a normal probability distribution, the odds of ResMed jumping above the current price in 90 days from now is about 85.27%. The ResMed Inc probability density function shows the probability of ResMed stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.608 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, ResMed will likely underperform. Additionally, resMed Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of ResMed to move above the current price in 90 days from now is about 85.27 (This ResMed Inc probability density function shows the probability of ResMed Stock to fall within a particular range of prices over 90 days) .
ResMed Stock Institutional Holders
Institutional Holdings refers to the ownership stake in ResMed that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of ResMed's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing ResMed's value.| Instituion | Recorded On | Shares | |
| Bank Of New York Mellon Corp | 2023-12-31 | 1.2 M | |
| Legal & General Group Plc | 2023-12-31 | 1.1 M | |
| Charles Schwab Investment Management Inc | 2023-12-31 | 863.3 K | |
| Fidelity International Ltd | 2023-12-31 | 840 K | |
| Jpmorgan Chase & Co | 2023-12-31 | 733.4 K | |
| Lgt Capital Partners Ltd. | 2023-12-31 | 683.8 K | |
| Voloridge Investment Management, Llc | 2023-09-30 | 662.4 K | |
| D. E. Shaw & Co Lp | 2023-09-30 | 657.3 K | |
| Amundi | 2023-12-31 | 615 K | |
| Vanguard Group Inc | 2023-12-31 | 17.7 M | |
| Blackrock Inc | 2023-12-31 | 12.2 M |
ResMed Historical Income Statement
ResMed Inc Income Statement is one of the three primary financial statements used for reporting ResMed's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of ResMed Inc revenue and expense. ResMed Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, ResMed's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 2.8 B, whereas Total Other Income Expense Net is forecasted to decline to (2.8 M). View More FundamentalsResMed Stock Against Markets
Picking the right benchmark for ResMed stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ResMed stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ResMed is critical whether you are bullish or bearish towards ResMed Inc at a given time. Please also check how ResMed's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in ResMed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
ResMed Corporate Directors
ResMed corporate directors refer to members of a ResMed board of directors. The board of directors generally takes responsibility for the ResMed's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of ResMed's board members must vote for the resolution. The ResMed board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| John Wareham | Independent Director | Profile | |
| Ronald Taylor | Lead Independent Director | Profile | |
| Gary Pace | Independent Director | Profile | |
| Agnes Lee | Senior Director - Investor Relations | Profile |
How to buy ResMed Stock?
Before investing in ResMed, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in ResMed. To buy ResMed stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of ResMed. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase ResMed stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located ResMed Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased ResMed Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as ResMed Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy ResMed Stock please use our How to Invest in ResMed guide.
Already Invested in ResMed Inc?
The danger of trading ResMed Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of ResMed is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than ResMed. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile ResMed Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Dividend Share 1.84 | Earnings Share 6.04 | Revenue Per Share 30.633 | Quarterly Revenue Growth 0.125 |
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.